- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 1/26 - Électrophorèse
Détention brevets de la classe C07K 1/26
Brevets de cette classe: 128
Historique des publications depuis 10 ans
3
|
12
|
9
|
8
|
9
|
7
|
10
|
7
|
4
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
ProteinSimple | 88 |
11 |
Bio-Rad Laboratories, Inc. | 1618 |
9 |
Regeneron Pharmaceuticals, Inc. | 4261 |
6 |
Enquyst Technologies Inc. | 11 |
5 |
Life Technologies Corporation | 3301 |
4 |
Kashiv Biosciences, LLC | 87 |
4 |
The Regents of the University of California | 19943 |
3 |
ARKRAY, Inc. | 869 |
3 |
University of Notre Dame du Lac | 563 |
3 |
The Johns Hopkins University | 5671 |
2 |
Agency for Science, Technology and Research | 3627 |
2 |
Terumo Kabushiki Kaisha | 5546 |
2 |
GE Healthcare Bio-Sciences AB | 541 |
2 |
Momenta Pharmaceuticals, Inc. | 290 |
2 |
Nabsys 2.0 LLC | 25 |
2 |
Temple University of the Commonwealth System of Higher Education | 618 |
2 |
Universal Bio Research Co., Ltd. | 129 |
2 |
The University of British Columbia | 1502 |
2 |
Memphasys Ltd | 11 |
2 |
Healthcare Financial Solutions, LLC, AS Agent (successor - in - interest to General Electric Capital Corp., AS Agent) | 10 |
2 |
Autres propriétaires | 58 |